Knowledge Distillery

After promising initial results from the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) to persons…

The emergence of the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 and the reduced effectiveness over time of the…

Studies examining epilepsy as a COVID-related death risk have come to conflicting conclusions. The aim of this study was to assess the prevalence of…

The exact incidence of neurological and cognitive sequelae of COVID-19 in the long term is yet unknown. The aim of this research is to investigate the…

There is growing evidence that severe acute respiratory syndrome coronavirus 2 can affect the CNS. However, data on white matter and cognitive…

Ocrelizumab maintains B-cell depletion via six-monthly dosing. Whilst this controls relapsing multiple sclerosis, it also inhibits seroconversion…

This study aimed to investigate the factors affecting the unwillingness of physicians involved in epilepsy care to continue telemedicine during the…

The objective of this case-control study was to assess risk factors for persistent neuropathic pain in subjects recovered from COVID-19 and to study…

Apolipoprotein E ε4 allele (APOE4) has been shown to associate with increased susceptibility to SARS-CoV-2 infection and COVID-19 mortality in some…

The objective of this article was to study the longitudinal seizure outcomes of people with epilepsy (PWE) following the acute and chronic phases of…

The objective of this study was to describe cerebrovascular, neuropathic and autonomic features of post-acute sequelae of COVID-19 (PASC). This…

In Switzerland, the COVID-19 incidence during the first pandemic wave was high. In this article the authors aimed to assess the association of the…